nitric oxide-donating compounds (Re-Vana Therapeutics/NicOx)

N/A

Report date: 2025/01/26 16:44:31
NME

Base Information

Drug Namenitric oxide-donating compounds (Re-Vana Therapeutics/NicOx)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide donors
TargetsUpdating
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRe-Vana Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRe-Vana Therapeutics LtdNicox SA
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A